SupporTive Care At Home Research for Patients With Advanced Cancer (STAHR-cancer)
HOMECARE
1 other identifier
interventional
396
1 country
6
Brief Summary
To test the effects of home-based care on unplanned hospitalization within 6 months among advanced cancer patients with decreased performance status. Home-based care includes education for patients and their family caregivers, home visits by specialized home-based medical staff, and regular status check-ups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2022
Longer than P75 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 25, 2022
CompletedFirst Submitted
Initial submission to the registry
October 17, 2022
CompletedFirst Posted
Study publicly available on registry
December 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
December 5, 2022
November 1, 2022
4.4 years
October 17, 2022
November 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Unplanned hospitalization
1. admission to the enrolled hospital to treat unexpected symptoms or medical conditions (not including planned admission for chemotherapy or admission for planned surgery or intervention) 2. admission to a hospital other than the enrolled hospital 3. admission to a nursing hospital for a duration of less than 4 weeks.
within 6 months following enrollment
Secondary Outcomes (17)
Patient medical utilization
within 6 months following enrollment
Hospitalization
within 6 months following enrollment
ER visits
within 6 months following enrollment
Healthcare use
within 6 months following enrollment
Patient end-of-life care: ICU admission
within 1 month before death
- +12 more secondary outcomes
Study Arms (2)
Intervention
EXPERIMENTALPatients enrolled in the intervention cluster (institution) are given specialized home-based medical care based on a specialized home-based medical team approach.
Control
NO INTERVENTIONPatients enrolled in the control cluster (institution) are only given the educational materials. Except for the home-based care intervention, usual care for advanced cancer patients was not restricted for these patients.
Interventions
Home-based medical care is based on a specialized home-based medical team approach, including following: 1. Specialized Home-Based Medical Team Approach 2. Initial Assessment and Education 3. Initial Home Visits and Education 4. Multidisciplinary Team Meeting 5. Regular Assessment After the Initial Visit
Eligibility Criteria
You may qualify if:
- Both the patient and their family caregiver must meet the criteria to be considered for this research.
- Patient
- A person who has an advanced-stage solid cancer diagnosis (ICD-10 code C00-C70); A person who is receiving or planning to receive cancer treatment
- A person who meets one of the following conditions
- Has been evaluated as having ECOG performance status 2
- Has been evaluated as having ECOG performance status 1 and is over 70 years of age
- A person who wishes to stay at home
- A person whose family caregiver resides at home
- A person who wishes to participate in the research
- Family Caregiver
- A family\* member of the patient
- \* Family: refers to the patient's spouse (including a common-law partner), descendants and their spouses up to the second degree, siblings and their spouses, and relatives and their spouses up to the eighth degree.
- A person who meets one of the following conditions:
- Lives with the patient (patient's household member)
- Does not live with the patient, but visits the patient's home more than three times a week
- +3 more criteria
You may not qualify if:
- If either the patient or the family caregiver meets any one of these criteria, they are excluded from the study.
- Patient
- A person who cannot speak, hear, or read Korean
- A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health
- A person residing outside the range that can be visited by the respective medical institution (the conditions for distance are to be specified by each medical institution)\*
- \* This condition is not applicable for the control group.
- A person who has used hospital- or home-type hospice and palliative care services
- A person who is under the age of 19
- Family Caregiver
- A person who cannot speak, hear, or read Korean
- A person who is judged by a medical doctor to be unable to take part in this research due to extremely poor health
- A person under the age of 19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Chung-Ang University Hosptial, Chung-Ang University College of Medicinecollaborator
- DongGuk Universitycollaborator
- Kyung Hee University Hospitalcollaborator
- Bundang CHA Hospitalcollaborator
- Seoul National University Bundang Hospitalcollaborator
Study Sites (6)
Dongguk University Medical Center
Goyang-si, Gyeonggi-do, South Korea
Bundang CHA Hospital
Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea
Seoul National University Hospital
Seoul, 03080, South Korea
Chung-Ang University Hosptial
Seoul, South Korea
Kyung Hee University Hospital
Seoul, South Korea
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Belong Cho, MD, MPH, PhD
Seoul National University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 17, 2022
First Posted
December 5, 2022
Study Start
July 25, 2022
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
December 5, 2022
Record last verified: 2022-11
Data Sharing
- IPD Sharing
- Will not share